Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
Clinical studies suggest that agonists at peroxisome proliferator-activated receptor gamma (PPARγ) may exert beneficial effects in patients with mild-to-moderate Alzheimer's disease (AD), but the mechanism for the potential therapeutic interest of this class of drugs has not yet been elucidated...
Main Authors: | , , , , , , , , , |
---|---|
Format: | info:eu-repo/semantics/article |
Language: | eng |
Published: |
NATURE PUBLISHING GROUP
2010
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/12953 |